Association of TRILEPTAL (oxcarbazepine) with Life-Threatening Dermatological Reactions and Multi-Organ Hypersensitivity – Novartis Pharmaceuticals Canada Inc. – For Health Professionals
Issued April 27, 2005
Issue
Hazard description
New safety information
Get notified of similar recallsEnter your email to receive alerts when new recalls are issued by the same agency.
Subscribed. You'll get an email when new recalls are issued.
RecallTracker